Stay updated on Empagliflozin Effects on Diastolic Function in Diabetics Clinical Trial

Sign up to get notified when there's something new on the Empagliflozin Effects on Diastolic Function in Diabetics Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Empagliflozin Effects on Diastolic Function in Diabetics Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the effects of empagliflozin on left ventricular diastolic function compared to usual care in individuals with type 2 diabetes in the EmDia trial, focusing on cardiovascular health and diabetes management.
    Difference
    0.1%
    Check dated 2024-06-06T14:27:48.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria.' This change provides a more detailed explanation of eligibility criteria, including examples such as a person's general health condition or prior treatments.
    Difference
    37%
    Check dated 2024-05-22T20:56:21.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T22:51:39.000Z thumbnail image

Stay in the know with updates to Empagliflozin Effects on Diastolic Function in Diabetics Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Empagliflozin Effects on Diastolic Function in Diabetics Clinical Trial page.